Notifications
15 minutes, 24 seconds
-10 Views 0 Comments 0 Likes 0 Reviews
The global assisted reproductive technology (ART) market is on a steady growth trajectory, valued at USD 23.54 billion in 2024. The market is expected to expand at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2034, reaching an estimated value of approximately USD 44.78 billion by 2034. ART includes various medical techniques and interventions designed to treat infertility, helping individuals and couples facing reproductive challenges to conceive.
Infertility affects millions of people globally, with one in six individuals of reproductive age experiencing fertility issues during their lifetime. The growing demand for ART solutions is being driven by factors such as changing lifestyle patterns, delayed pregnancies, and rising awareness of fertility treatments. Furthermore, advancements in ART technologies, along with improved success rates and better accessibility, are contributing to the market's expansion.
ART encompasses procedures such as in vitro fertilization (IVF), intrauterine insemination (IUI), egg/sperm donation, and cryopreservation of embryos, among others. These techniques offer hope to individuals dealing with infertility caused by conditions like polycystic ovary syndrome (PCOS), endometriosis, sexually transmitted infections (STIs), and primary ovarian insufficiency (POI). The increasing awareness of infertility treatments and the rising prevalence of fertility-related disorders are key drivers of growth in the ART market.
As of 2024, the global ART market size is valued at USD 23.54 billion. The increasing need for advanced fertility treatments, combined with technological advancements in the ART field, is expected to drive continued market growth. By 2034, the market is projected to reach approximately USD 44.78 billion, expanding at a CAGR of 6.50%.
In Vitro Fertilization (IVF): IVF remains the largest segment of the ART market, contributing a substantial share. IVF is a widely accepted and effective treatment for infertility, particularly in cases where other methods fail. It involves combining eggs and sperm outside the body to create embryos, which are then implanted in the uterus.
Intrauterine Insemination (IUI): IUI is another popular ART method that involves placing sperm directly into the uterus. It is commonly used in cases of mild male infertility or unexplained infertility and is less invasive compared to IVF.
Egg/Sperm Donation: The use of donated eggs or sperm is growing, especially among individuals facing challenges with their reproductive cells. Egg/sperm donation helps individuals who cannot conceive with their own eggs or sperm to achieve successful pregnancies.
Cryopreservation: Cryopreservation, or the freezing of eggs, sperm, and embryos, is increasingly used in ART procedures. It enables the storage of reproductive cells for future use, offering greater flexibility and increasing the chances of successful pregnancies.
Fertility Clinics: Fertility clinics dominate the ART market due to the increasing number of people seeking assisted reproductive treatments. These clinics offer a range of ART services, from IVF to sperm/egg donation and embryo freezing.
Hospitals: Many hospitals are expanding their reproductive healthcare offerings, providing ART services within their obstetrics and gynecology departments. The increasing number of healthcare facilities offering ART treatments is helping to drive market growth.
Home Healthcare: In some regions, home-based ART treatments such as ovulation prediction kits and at-home sperm analysis services are gaining popularity, although this segment still holds a relatively smaller market share.
North America: North America, particularly the United States, is the largest regional market for ART. A combination of advanced healthcare infrastructure, high awareness of ART treatments, and increasing adoption of assisted reproductive procedures are driving this growth.
Europe: Europe also holds a significant share of the ART market, with countries like Spain, Italy, and the UK contributing to the demand for IVF and other ART services. European countries offer advanced ART services with high success rates, attracting patients from around the world.
Asia-Pacific: The Asia-Pacific region is expected to experience significant growth in the ART market during the forecast period. Rising fertility issues, coupled with increasing awareness of ART and improvements in healthcare systems, are contributing to market expansion in countries like India, China, and Japan.
Rest of the World: The demand for ART services in Latin America, the Middle East, and Africa is also increasing, particularly in countries like Brazil, UAE, and South Africa, due to a growing focus on improving healthcare access and treatments for infertility.
Explore More Information in Assisted Reproductive Technology Market
Rising Prevalence of Infertility: One of the primary drivers of the ART market is the increasing prevalence of infertility. Infertility affects millions of people worldwide due to various reasons, including lifestyle factors, delayed pregnancies, and medical conditions such as PCOS and endometriosis. ART provides a critical solution to these challenges, fostering market growth.
Delayed Pregnancies and Changing Lifestyles: As societal norms change, more people are delaying marriage and childbirth. The trend of delayed pregnancies, coupled with busy and stressful lifestyles, has led to an increase in infertility cases, driving the demand for ART treatments.
Technological Advancements in ART: Advancements in ART technologies, such as improved IVF techniques, genetic screening of embryos, and better cryopreservation methods, have significantly increased success rates, making ART procedures more reliable and effective. These technological advancements are contributing to the market's rapid expansion.
Government Initiatives and Investments: Government initiatives promoting awareness of fertility treatments and funding for research and development in ART technologies are boosting market growth. Additionally, favorable reimbursement policies in developed regions are making ART treatments more accessible to a broader population.
Personalized and Precision Medicine: Increasingly, ART treatments are becoming more personalized. With advancements in genetic screening, IVF procedures can be customized to the genetic profile of patients, enhancing the likelihood of successful pregnancies.
Expansion of Fertility Tourism: Fertility tourism, where patients travel abroad for ART treatments, is gaining traction. Patients are seeking ART services in countries with lower treatment costs or more advanced fertility technologies, contributing to the global demand for ART.
Focus on Male Infertility: While ART treatments have traditionally focused on female infertility, there is a growing emphasis on addressing male infertility. Techniques such as sperm retrieval and sperm cryopreservation are seeing increased demand, reflecting the growing recognition of male reproductive health.
The ART market is poised for substantial growth due to increasing demand for fertility treatments and technological advancements that improve the success rates of ART procedures. Fertility clinics, hospitals, and other healthcare facilities are expanding their ART services to cater to the growing number of individuals seeking help with infertility.
The market is also experiencing growth due to increasing awareness of infertility-related issues, as well as government policies that support access to reproductive healthcare. With the development of new technologies and a greater understanding of the causes of infertility, ART is expected to become more effective and accessible to patients worldwide.
Expanding Healthcare Infrastructure in Developing Regions: As healthcare systems in developing countries improve, the demand for ART services is expected to rise. Investment in fertility clinics and healthcare facilities in regions like Africa, Asia, and Latin America presents significant growth opportunities for the market.
Growth of Fertility Preservation Services: Increasing awareness about fertility preservation, particularly among individuals who wish to delay childbirth for personal or medical reasons, presents an opportunity for ART providers to offer egg, sperm, and embryo freezing services.
Rising Demand for Surrogacy and Egg/Sperm Donation: With an increasing number of individuals and couples turning to surrogacy and egg/sperm donation for reproductive assistance, ART providers have the opportunity to diversify their service offerings to meet this demand.
High Costs of ART Treatments: One of the key challenges for the ART market is the high cost of procedures, which may be prohibitive for some individuals and couples. While ART treatments are becoming more accessible, affordability remains a concern in many regions.
Ethical and Legal Issues: Ethical concerns regarding ART practices, including embryo screening and genetic testing, as well as legal issues related to egg/sperm donation and surrogacy, may pose challenges to market growth in some countries.
Complications in ART Procedures: While ART procedures have improved significantly, complications, such as multiple pregnancies and health risks for mothers, remain potential concerns. Continued advancements in techniques and safety measures will be essential to mitigate these risks.
Several developments have shaped the ART market in recent years:
Advancements in IVF Technologies: The use of genetic screening and embryo cryopreservation has significantly improved IVF success rates, making the procedure more effective and widely adopted.
Expansion of ART Services Globally: ART services are expanding globally, particularly in developing countries, where healthcare systems are improving, and demand for fertility treatments is rising.
Increased Focus on Male Infertility: There has been a growing recognition of male infertility, with increased investment in technologies to address this issue, such as sperm retrieval and cryopreservation.
The global ART market features several key players that are driving innovation and shaping the industry:
Microm U.K. Ltd.
CooperSurgical, Inc.
FUJIFILM Irvine Scientific
Cyprus IVF Centre
Vita Altera IVF Center
Cryolab Ltd.
Vitrolife AB
European Sperm Bank
Bloom IVF Centre
Merck KGaA
These companies are advancing ART technologies, expanding their service offerings, and tapping into new markets to meet the growing demand for fertility treatments globally.
Assisted Reproductive Technology (ART) encompasses medical techniques used to treat infertility, including procedures like in vitro fertilization (IVF), intrauterine insemination (IUI), and egg/sperm donation.
The global ART market was valued at USD 23.54 billion in 2024 and is projected to expand at a CAGR of 6.50% from 2025 to 2034, reaching approximately USD 44.78 billion by 2034.
Key factors driving the ART market include the rising prevalence of infertility, changing lifestyle patterns, delayed pregnancies, and advancements in ART technologies that improve treatment outcomes.
Major trends include personalized ART treatments, fertility tourism, increased focus on male infertility, and the growth of fertility preservation services.
Key players in the ART market include Microm U.K. Ltd., CooperSurgical, FUJIFILM Irvine Scientific, Vitrolife AB, and Merck KGaA.
Read More Report:
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others. Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Deepanshu Choudhary, Digital Marketing
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
Assisted Reproductive Technology Market Assisted Reproductive Technology Market Size Assisted Reproductive Technology Market Trend
){kind=link}
){kind=link}